D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 41 Citations 8,941 79 World Ranking 16120 National Ranking 178

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Immune system
  • Enzyme

Her main research concerns Mycobacterium tuberculosis, Tuberculosis, Adjuvant, Immunology and ESAT-6. Her Mycobacterium tuberculosis study combines topics in areas such as Proteome and Molecular biology. Ida Rosenkrands combines subjects such as Gene, Sequence analysis and Microbiology with her study of Tuberculosis.

As a member of one scientific family, Ida Rosenkrands mostly works in the field of Adjuvant, focusing on Immune system and, on occasion, Secretion. As a part of the same scientific study, Ida Rosenkrands usually deals with the Immunology, concentrating on Virology and frequently concerns with Antigen. Her work in ESAT-6 tackles topics such as Mycobacterium bovis which are related to areas like Immunodominance and Tuberculosis vaccines.

Her most cited work include:

  • Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis (485 citations)
  • A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). (430 citations)
  • ESAT-6 Subunit Vaccination against Mycobacterium tuberculosis (331 citations)

What are the main themes of her work throughout her whole career to date?

Mycobacterium tuberculosis, Tuberculosis, Immunology, Antigen and Virology are her primary areas of study. Her research on Mycobacterium tuberculosis focuses in particular on ESAT-6. Her study looks at the relationship between Tuberculosis and topics such as Disease, which overlap with Prospective cohort study.

Her Antigen study also includes fields such as

  • Immune system, which have a strong connection to Adjuvant and Chlamydia sp,
  • Recombinant DNA together with Molecular biology and Gel electrophoresis. Ida Rosenkrands interconnects Epitope, Antibody, Cellular immunity and Tuberculosis vaccines in the investigation of issues within Virology. Her Microbiology study incorporates themes from Mycobacterium bovis and In vitro.

She most often published in these fields:

  • Mycobacterium tuberculosis (47.06%)
  • Tuberculosis (39.22%)
  • Immunology (39.22%)

What were the highlights of her more recent work (between 2015-2021)?

  • Immunology (39.22%)
  • Antigen (36.27%)
  • Tuberculosis (39.22%)

In recent papers she was focusing on the following fields of study:

Her primary areas of study are Immunology, Antigen, Tuberculosis, Immune system and Mycobacterium tuberculosis. Her work on Antibody and Priming as part of general Immunology study is frequently connected to C-C chemokine receptor type 6, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Her studies in Antigen integrate themes in fields like T cell, T cell differentiation, Microbiology and Vaccination.

Her Tuberculosis study combines topics from a wide range of disciplines, such as Internal medicine and Disease. Her Immune system research integrates issues from Chlamydia sp, Biochemistry, Nucleic acid and Virology. Ida Rosenkrands works mostly in the field of Mycobacterium tuberculosis, limiting it down to concerns involving Protein subunit and, occasionally, Bacillus Calmette-Guerin vaccination and Mycobacterium.

Between 2015 and 2021, her most popular works were:

  • Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB (73 citations)
  • Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses. (68 citations)
  • Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis (25 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Immune system

Her primary areas of study are Immunology, Tuberculosis, Disease, Antibody and Internal medicine. In general Immunology study, her work on Antigen and Bacterial vaccine often relates to the realm of Germinal center and C-C chemokine receptor type 6, thereby connecting several areas of interest. The Antigen study combines topics in areas such as Serology, Outpatient clinic and Confidence interval.

Active tb and Pulmonary tuberculosis are the core of her Tuberculosis study. Ida Rosenkrands focuses mostly in the field of Antibody, narrowing it down to topics relating to Chlamydia and, in certain cases, Virology. Her biological study spans a wide range of topics, including Epitope, Cytokine, Ferritin and Mycobacterium tuberculosis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10).

Fransois-Xavier Berthet;Peter Birk Rasmussen;Ida Rosenkrands;Peter Andersen.
Microbiology (1998)

704 Citations

Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis

Vadim Makarov;Giulia Manina;Katarina Mikusova;Ute Möllmann.
Science (2009)

656 Citations

ESAT-6 Subunit Vaccination against Mycobacterium tuberculosis

Lise Brandt;Martin Elhay;Ida Rosenkrands;Erik B. Lindblad.
Infection and Immunity (2000)

470 Citations

Human T Cell Responses to the ESAT-6 Antigen from Mycobacterium tuberculosis

Pernille Ravn;Abebech Demissie;Tewodros Eguale;Hailu Wondwosson.
The Journal of Infectious Diseases (1999)

459 Citations

Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells

Thomas Lindenstrøm;Else Marie Agger;Karen S. Korsholm;Patricia A. Darrah.
Journal of Immunology (2009)

451 Citations

Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens.

Rikke Louise Vinther Skjøt;Thomas Oettinger;Ida Rosenkrands;Pernille Ravn.
Infection and Immunity (2000)

411 Citations

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate) - A novel adjuvant inducing both strong CMI and antibody responses

Jesper Davidsen;Ida Rosenkrands;Dennis Christensen;Anil Vangala.
Biochimica et Biophysica Acta (2005)

397 Citations

ESAT-6 proteins: protective antigens and virulence factors?

Priscille Brodin;Ida Rosenkrands;Peter Andersen;Stewart T. Cole.
Trends in Microbiology (2004)

390 Citations

Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements

Else Marie Agger;Ida Rosenkrands;Jon Hansen;Karima Brahimi.
PLOS ONE (2008)

281 Citations

Cationic liposomes as vaccine adjuvants

Dennis Christensen;Karen S Korsholm;Ida Rosenkrands;Thomas Lindenstrøm.
Expert Review of Vaccines (2007)

278 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ida Rosenkrands

Peter E. Andersen

Peter E. Andersen

Technical University of Denmark

Publications: 180

Stewart T. Cole

Stewart T. Cole

Institut Pasteur

Publications: 110

Tom H. M. Ottenhoff

Tom H. M. Ottenhoff

Leiden University Medical Center

Publications: 69

Else Marie Agger

Else Marie Agger

Novo Nordisk (Denmark)

Publications: 67

Roland Brosch

Roland Brosch

Institut Pasteur

Publications: 60

Stefan H. E. Kaufmann

Stefan H. E. Kaufmann

Max Planck Institute for Infection Biology

Publications: 57

Robert J. Wilkinson

Robert J. Wilkinson

The Francis Crick Institute

Publications: 47

Gerhard Walzl

Gerhard Walzl

Stellenbosch University

Publications: 42

Steven G. Reed

Steven G. Reed

Infectious Disease Research Institute

Publications: 42

Warwick J. Britton

Warwick J. Britton

University of Sydney

Publications: 37

Claude Leclerc

Claude Leclerc

Inserm : Institut national de la santé et de la recherche médicale

Publications: 36

Willem A. Hanekom

Willem A. Hanekom

University College London

Publications: 34

Wilbert Bitter

Wilbert Bitter

Vrije Universiteit Amsterdam

Publications: 34

Abu Salim Mustafa

Abu Salim Mustafa

Kuwait University

Publications: 32

Thomas J. Scriba

Thomas J. Scriba

University of Cape Town

Publications: 32

Gurdyal S. Besra

Gurdyal S. Besra

University of Birmingham

Publications: 31

Trending Scientists

Robert B. Fisher

Robert B. Fisher

University of Edinburgh

Hugh E Williams

Hugh E Williams

University of Melbourne

Vincenzo Barone

Vincenzo Barone

Scuola Normale Superiore di Pisa

Anita C. Risch

Anita C. Risch

Swiss Federal Institute for Forest, Snow and Landscape Research

Egbert F. Knol

Egbert F. Knol

Topigs Norsvin (Netherlands)

Palle Serup

Palle Serup

University of Copenhagen

Larry S. Sherman

Larry S. Sherman

Oregon National Primate Research Center

Gary Thomas

Gary Thomas

University of Pittsburgh

Arnold E. Postlethwaite

Arnold E. Postlethwaite

University of Tennessee Health Science Center

Kei Sakamoto

Kei Sakamoto

University of Copenhagen

Hubert Laude

Hubert Laude

University of Paris-Saclay

Dudley B. Chelton

Dudley B. Chelton

Oregon State University

W. Conrad Liles

W. Conrad Liles

University of Washington

Jeffrey F. Peipert

Jeffrey F. Peipert

Indiana University

Carolyn M. Callahan

Carolyn M. Callahan

University of Virginia

Luigi Stella

Luigi Stella

National Institute for Astrophysics

Something went wrong. Please try again later.